Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Astellas/Pfizer’s COX-2 Inhibitor Celecox Gains Additional Indications In Japan

Jun 22 2009

• By PharmAsia News

Related Content

Pfizer Forks Over $894 Million To Settle Celebrex/Bextra Litigation

Oct 17 2008

Daiichi Sankyo Seeking Small Biotech Acquisitions In Europe

Jun 15 2009

Takeda Takes Back Actos Rights from Eli Lilly, Sets Course For Own Geographic Expansion

Apr 12 2009

More from Archive

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window